These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 523586)

  • 1. Prolonged decrease of serum prolactin in rat by an ester prodrug of apomorphine.
    Baldessarini RJ; Boyd AE; Kula NS; Borgman RJ
    Psychoneuroendocrinology; 1979; 4(2):173-5. PubMed ID: 523586
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels.
    Meltzer HY; Simonovic M
    Life Sci; 1981 Jul; 29(1):99-105. PubMed ID: 7196483
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of apomorphine hydrochloride, dibutyryl-apomorphine and Lysenyl on plasma prolactin concentrations in the rat.
    Horowski R; Neumann F; Gräf KJ
    J Pharm Pharmacol; 1975 Jul; 27(7):532-4. PubMed ID: 239161
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulatory effect of dopamine receptor agonists on prolactin secretion by cultured rat pituitary cells [proceedings].
    Denef C
    Arch Int Physiol Biochim; 1979 Oct; 87(4):802-3. PubMed ID: 93913
    [No Abstract]   [Full Text] [Related]  

  • 6. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
    [No Abstract]   [Full Text] [Related]  

  • 7. An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
    Baldessarini RJ; Neumeyer JL; Campbell A; Sperk G; Ram VJ; Arana GW; Kula NS
    Eur J Pharmacol; 1982 Jan; 77(1):87-8. PubMed ID: 6277658
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulatory control of prolactin by dopamine.
    Brown GM; Seggie JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of dopaminergic inhibition of luteinizing hormone release in immature and castrated female rats.
    Beck W; Hancke JL; Wuttke W
    Endocrinology; 1978 Mar; 102(3):837-43. PubMed ID: 743997
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of the dopaminergic inhibition of pituitary luteinizing hormone release by prolactin in ovariectomized rats.
    Beck W; Wuttke W
    J Endocrinol; 1977 Jul; 74(1):67-74. PubMed ID: 874418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester.
    Scatton B; Worms P
    J Pharm Pharmacol; 1979 Dec; 31(12):861-3. PubMed ID: 43377
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of aporphine isomers on rat prolactin.
    Baldessarini RJ; Campbell A; Ben-Jonathan N; Ellingboe J; Zong R; Neumeyer JL
    Neurosci Lett; 1994 Aug; 176(2):269-71. PubMed ID: 7830962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of arecoline and apomorphine and the site of action of arecoline in inhibiting the diurnal prolactin surge.
    Subramanian MG; Gala RR
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):353-6. PubMed ID: 560020
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged apomorphine-like behavioural effects of apomorphine esters.
    Borgman RJ
    Neuropharmacology; 1976 Aug; 15(8):471-8. PubMed ID: 988501
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.
    Rusterholz DB; Long JP; Flynn JR; Cannon JG; Lee T; Pease JP; Clemens JA; Wong DT; Bymaster FP
    Eur J Pharmacol; 1979 Apr; 55(1):73-82. PubMed ID: 571341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of apomorphine on serum prolactin level in the male.
    Brown WA
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):671-4. PubMed ID: 1179038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.